David Shaw’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-34,200
Closed -$2.71M 4009
2019
Q4
$2.71M Sell
34,200
-25,000
-42% -$1.92M ﹤0.01% 2223
2019
Q3
$4.37M Buy
+59,200
New +$4.25M 0.01% 1752
2019
Q1
Sell
-46,900
Closed -$3.43M 3674
2018
Q4
$3.43M Buy
+46,900
New +$3.74M ﹤0.01% 1757
2016
Q2
Sell
-43,000
Closed -$3.11M 3371
2016
Q1
$3.11M Sell
43,000
-82,400
-66% -$5.4M 0.01% 1583
2015
Q4
$8.47M Buy
125,400
+43,000
+52% +$3.01M 0.01% 1047
2015
Q3
$5.33M Buy
82,400
+7,500
+10% +$554K 0.01% 1353
2015
Q2
$6.13M Buy
74,900
+44,100
+143% +$3.4M 0.01% 1321
2015
Q1
$2.13M Sell
30,800
-235,500
-88% -$17M ﹤0.01% 1959
2014
Q4
$20.2M Hold
266,300
0.03% 716
2014
Q3
$21.5M Sell
266,300
-57,000
-18% -$4.76M 0.03% 663
2014
Q2
$28.2M Buy
323,300
+10,800
+3% +$938K 0.04% 519
2014
Q1
$26.9M Buy
312,500
+20,000
+7% +$1.64M 0.04% 505
2013
Q4
$23.6M Hold
292,500
0.03% 594
2013
Q3
$22.8M Sell
292,500
-20,300
-6% -$1.56M 0.04% 528
2013
Q2
$21.9M Buy
+312,800
New +$21.8M 0.04% 487

Other funds holding EMN

David Shaw's EMN Position: Q2 2026 in Review

David Shaw reduced its Eastman Chemical (EMN) stake by 87% in Q2 2026, selling an estimated $27.1M and leaving 56,599 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2647.

David Shaw first reported a position in EMN in Q3 2013 and has held it in 47 quarters since. The position peaked at $68.6M in Q4 2013. 639 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • David Shaw held 56,599 shares of Eastman Chemical worth $3.79M as of Q2 2026.
  • David Shaw sold 370,694 Eastman Chemical shares in Q2 2026, an estimated $27.1M.
  • Eastman Chemical made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2647 holding.
  • David Shaw first reported a position in Eastman Chemical in Q3 2013 and has held it in 47 quarters since.
  • David Shaw's Eastman Chemical position peaked at $68.6M in Q4 2013.
  • 639 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.